Author

Shashank Kumar Ojha

Observed names: Shashank Ojha, ShashankKumar Ojha

Institution: Hebrew University of Jerusalem

Observed institutions: Hebrew University of Jerusalem, Homi Bhabha National Institute, Tata Memorial Hospital, Advanced Centre for Treatment, Research and Education in Cancer

ORCID: 0000-0001-9457-2576

Observed ORCID: 0000-0001-9457-2576

OpenAlex ID: A5084499639

Air pollution: an emerging risk factor for autism spectrum disorder

2024 · Shashank Kumar Ojha, Haitham Amal · Brain medicine : · 8

Blocking nitric oxide production for glioblastoma: A targeted therapeutic approach

2025 · Shashank Kumar Ojha, Wisam Bazbaz, et al. · Brain medicine : · 3

Blood components utilization in hematopoietic stem cell transplantation: Thirteen-year analysis from an apex oncology center of India

2022 · Shashank Ojha, Vijaya Patle, et al. · Asian Journal of Transfusion Science · 3

Autolysosomal enhancer GHF201 attenuates pathophysiology in a mucopolysaccharidosis type I mouse model

2026 · Pradeep Kumar, Emmanuelle Merquiol, et al. · Life Science Alliance

Targeting Temozolomide‐Resistant Glioblastoma: Therapeutic Potential of Neuronal Nitric Oxide Synthase Inhibitor

2026 · Mallikarjuna Nimgampalle, Shashank Kumar Ojha, et al. · Cancer Medicine

Targeting nNOS suppresses AKT–TSC–mTOR signaling and inhibits neuroblastoma growth

2026 · Shashank Kumar Ojha, Manish Kumar Tripathi, et al. · Brain medicine :

Implication and Importance of Stem Cell Therapy in a Translational Model of Neurodegenerative Diseases

2024 · Shashank Kumar Ojha · Neurodegenerative Diseases

Bioactives as Modulators of β‐cells and Immunity in Therapy of Type 1 Diabetes Mellitus

2023 · ShashankKumar Ojha

Works count: 8

Citation count: 14

H-index: 3

I10-index: